These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9465187)

  • 1. Immunology. New clues to systemic lupus.
    Bach JF; Koutouzov S
    Lancet; 1997 Dec 20-27; 350 Suppl 3():SIII11. PubMed ID: 9465187
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular mimicry in systemic lupus erythematosus.
    Agmon-Levin N; Blank M; Paz Z; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1181-5. PubMed ID: 19880565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in systemic lupus erythematosus--there before you know it.
    Shmerling RH
    N Engl J Med; 2003 Oct; 349(16):1499-500. PubMed ID: 14561791
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation-associated Ki-67 protein is a target for autoantibodies in the human autoimmune disease systemic lupus erythematosus.
    Gerlach C; Kubbutat M; Schwab U; Key G; Flad HD; Gerdes J
    Lab Invest; 1998 Jan; 78(1):129-30. PubMed ID: 9461130
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recent aspects of selected autoantibodies in patients with systemic lupus erythematosus and their clinical relevance. I. DNA-binding autoantibodies].
    Wollina U
    Allerg Immunol (Leipz); 1983; 29(3):127-34. PubMed ID: 6227213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of systemic lupus erythematosus. Possible participation of antiphospholipid antibodies.
    Alarcón-Segovia D
    Isr J Med Sci; 1989 Dec; 25(12):669-74. PubMed ID: 2693397
    [No Abstract]   [Full Text] [Related]  

  • 8. Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus.
    van Bavel CC; Dieker JW; Kroeze Y; Tamboer WP; Voll R; Muller S; Berden JH; van der Vlag J
    Ann Rheum Dis; 2011 Jan; 70(1):201-7. PubMed ID: 20699234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to ribosomal P proteins in systemic lupus erythematosus.
    Ghirardello A; Doria A; Zampieri S; Gambari PF; Todesco S
    Isr Med Assoc J; 2001 Nov; 3(11):854-7. PubMed ID: 11729585
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent aspects of selected autoantibodies in patients with systemic lupus erythematodes and their clinical significance. III. RNA-fixing autoantibodies, ribonucleoprotein autoantibodies].
    Wollina U
    Allerg Immunol (Leipz); 1983; 29(4):191-9. PubMed ID: 6198890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus.
    Rahman A; Isenberg DA
    N Engl J Med; 2008 Feb; 358(9):929-39. PubMed ID: 18305268
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunopathology of systemic lupus erythematosus].
    Bach JF
    Rev Med Interne; 2000 Dec; 21 Suppl 4():456s. PubMed ID: 11347482
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-telomere antibodies in systemic lupus erythematosus.
    Reichlin M
    Lupus; 2000; 9(5):317. PubMed ID: 10878720
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic lupus erythematosus.
    Reichlin M
    Immunol Ser; 1991; 54():163-99. PubMed ID: 1954275
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of experimental systemic lupus erythematosus in mice.
    Mozes E; Shoenfeld Y; Brocke S; Mendlovic S
    Isr J Med Sci; 1988 Dec; 24(12):741-4. PubMed ID: 3225187
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoantibodies against complement components in systemic lupus erythematosus - role in the pathogenesis and clinical manifestations.
    Hristova MH; Stoyanova VS
    Lupus; 2017 Dec; 26(14):1550-1555. PubMed ID: 29092674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus].
    Pozsonyi T; Lakos G; Jakab L; Baraczka K; Jánoskuti L; Kleiber M; Sipka S; Pajor A; Szegedi G
    Orv Hetil; 1998 Oct; 139(40):2363-8. PubMed ID: 9796352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contributions of the INCMNSZ to medicine: Thrombosis, antibodies, and systemic lupus erythematosus].
    Ruiz-Argüelles GJ; Ruiz-Argüelles A
    Rev Invest Clin; 2000; 52(4):473. PubMed ID: 11061113
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro production of antihistone antibodies in systemic lupus erythematosus (SLE).
    Gioud-Paquet M; Martinon S; Bouvier M; Lejeune E; Monier JC
    Thymus; 1987; 9(2):127-9. PubMed ID: 3590273
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenic role of auto-antibodies against complement components in systemic lupus erythematosus.
    Daha MR
    Lupus; 2008 May; 17(5):385-8. PubMed ID: 18490413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.